Lapse and Forfeit of Unlisted Conditional Performance Rights

05 December 2017

CLINUVEL PHARMACEUTICALS LTD (ASX: CUV; XETRA-DAX: UR9; NASDAQ INTERNATIONAL DESIGNATION ADR: CLVLY) wishes to advise in accordance with the terms and conditions of issue that the unquoted performance rights enclosed have lapsed and forfeited.

Download PDF for more

We use cookies to give you the best experience.